Psoriasis Market (Plaque, Guttate, Inverse, Pustular, Erytherodermic) Trends, Growth Drivers and Forecasts to 2020

PUNE, India, July 13, 2016 /PRNewswire/ --

MarketReportsOnline.com adds Global Psoriasis Market with Focus on Plaque Psoriasis: Outlook to 2020 research report of 45 pages on the Psoriasis industry to the pharmaceuticals intelligence collection of its research store.

Psoriasis is a chronic inflammatory skin disease primarily causing scaling and inflammation of skin, characterized by sharply demarcated, scaly, red skin lesions most often on the elbows, knees, scalps, hands and feet. It occurs when the body's immune system sends out faulty signals that speed up the growth cycle of skin cells. Psoriasis has been majorly classified into Plaque psoriasis, Guttate psoriasis, Inverse psoriasis, Pustular psoriasis and Erytherodermic psoriasis. It is an autoimmune disease and may be triggered by smoking, alcohol consumption, cold or dry weather and stress. Complete report on Psoriasis market providing 4 company profiles and 7 tables and 28 charts is now available at http://www.marketreportsonline.com/491196.html.  

In the wake of lesser treatment options and costly therapies, psoriasis remains as an under treated disease. Psoriasis treatment can be divided into three main groups: topical treatment, light therapy, and systemic medication based on the severity of the disease. The typical treatment options include TNF inhibitors and IL inhibitors. However, various therapies and drugs are in the pipeline and it is expected that treatment options will improve over time with higher efficacy and lower costs.

The global market for psoriasis has been increasing consistently over the last few years. The major factors contributing to the growth of the global psoriasis market are increasing smoking and alcohol consumption trends globally. Surging smoking population, increased spending on medicines, increasing sales of prescription drugs and escalating health care expenditure are the key growth drivers of the market. However, growth of the market is hindered by extensive drug development and approval process and side-effects associated with the existing medication for psoriasis.

Various treatment methods are readily used to control psoriasis in the US, such as TNFs, systemics and topicals. With relatively higher prevalence rates in the US, several companies are trying to grab larger market shares with their new and innovative drugs. Plaque psoriasis is a common form of this disease in the US with increasing prevalence each year.

Purchase a copy of this Global Psoriasis Market with Focus on Plaque Psoriasis: Outlook to 2020 research report at http://www.marketreportsonline.com/contacts/purchase.php?name=491196.

The report "Global Psoriasis Market" analyzes the development of this market, with focus on the US treatment market. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players: Johnson and Johnson, Abbvie inc., Amgen Inc. and Novartis are being profiled along with their key financials and strategies for growth.

Major Points from Table of Contents Provided in Global Psoriasis Market Report: 

1. Market Overview

1.1 Psoriasis

1.2 Types

1.2.1 Plaque Psoriasis

1.2.2 Guttate Psoriasis

1.2.3 Inverse Psoriasis

1.2.4 Pustular Psoriasis

1.2.5 Erytherodermic Psoriasis

1.3 Causes

1.4 Symptoms by Types

1.4.1 Plaque Psoriasis

1.4.2 Guttate Psoriasis

1.4.3 Inverse Psoriasis

1.4.4 Pustular Psoriasis

1.4.5 Erytherodermic Psoriasis

1.5 Diagnosis

1.6 Treatment Options

1.6.1 Topical Treatments

1.6.2 Light Therapy or Phototherapy

1.6.3 Systemic Treatments

2. Global Market

3. The US Market

4. Market Dynamics

Another Report on Psoriasis Market titled Chronic Plaque Psoriasis - Pipeline Insights, 2016 provides in depth insights on the pipeline drugs and their development activities around the Chronic Plaque Psoriasis. This Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. Complete report is now available at http://www.marketreportsonline.com/439354.html.

Explore more pharmaceuticals market research as well as other newly published reports by Koncept Analytics at http://www.marketreportsonline.com/publisher/koncept-analytics-market-research.html.

About Us:  

Market Reports Online comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Contact Us:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
Tel: + 1 888 391 5441
E-mail: sales@marketreportsonline.com